Le Lézard
Classified in: Health, Science and technology
Subject: PER

Stratus Appoints David N. Hruda Chief Compliance Officer


IRVING, Texas, Nov. 25, 2020 /PRNewswire-PRWeb/ -- Stratus, the nation's leading provider of in-home neurodiagnostic testing services, today announced the appointment of David N. Hruda as chief compliance officer.

As chief compliance officer, Hruda will be responsible for overseeing compliance, risk, and ethics within the organization, and ensuring adherence with laws and regulatory requirements. He will focus on developing, implementing, and overseeing compliance policies and procedures, as well as programs to prevent, detect, and take appropriate remedial measures to address any non-compliance. Hruda will report directly to Charlie Alvarez, chief executive officer and the company's board of directors.

Hruda joins Status with more than 20 years of legal, compliance, and business experience. Prior to joining Stratus, he served as Vice President of Legal and Compliance for BioSerenity, Inc, a global company that provides services in sleep, electroencephalogram (EEG), and cardiac diagnostics. Hruda was responsible for providing counsel on compliance, risk management, healthcare regulations, and data privacy.

"Stratus is commited to providing safe and quality care to our physicians and patients, as well as to conducting our business with the highest level of integrity and compliance," said Charlie Alvarez, chief executive officer of Stratus. "David's qualifications and his proven track record leading regulatory and compliance in the health care industry make him the perfect fit for the company. His addition to our leadership team will help us further our commitment to conduct business ethically and in compliance with the laws and regulations that govern our business and industry."

Prior to BioSerenity, Hruda was senior attorney at the law firm of Alexander & Cleaver. In this role, he advised clients on HIPAA, HITECH and the design and implementation of compliance programs. Hruda has also served as chief compliance officer and general counsel for Watermark Medical Holdings, Inc. He was part of the company startup, advising leadership on compliance, risk management, and healthcare regulations. Hruda's additional start-up company experience includes time as the chief compliance officer at PDSHeart, Inc., which was acquired by CardioNet, Inc, now known as Biotel.

Hruda earned a Bachelor's Degree in Social Sciences from the University of Maryland. He earned his JD from the University of Baltimore School of Law.

For more information on Stratus, visit http://www.stratusneuro.com.

About Stratus
Stratus is the nation's leading provider of ambulatory in-home video EEG and has served more than 60,000 patients across the U.S. The company offers technology, services, and proprietary software solutions to help neurologists accurately and quickly diagnose their patients with epilepsy and other seizure-like disorders. Stratus also provides mobile cardiac telemetry to support the diagnostic testing needs of the neurology community. Additionally, the company's R&D division holds the world's largest database of de-identified EEG recordings and is applying machine learning to improve the overall quality and efficiency of EEG testing. To learn more, visit http://www.stratusneuro.com.

Media Contact

Jennifer Armstrong, Stratus, +1 (972) 743-8992, Jennifer.Armstrong@stratusneuro.com

 

SOURCE Stratus


These press releases may also interest you

at 02:00
Chaser Technologies Limited (Chaser), the global credit control automation platform, today announced the release of a Payment Portal, in app, that enables the customers of users to see all invoices due in one place and pay them instantly. Chaser has...

22 jan 2021
From President Joe Biden's Administration platform, to organizations such as B Corporation, to global enterprises; many have focused their attention to Clean Energy. Studies have already proven that Urban areas account for more than 70% of CO2...

22 jan 2021
Aurinia Pharmaceuticals Inc. ("Aurinia" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has approved LUPKYNISTM (voclosporin) in combination with a background immunosuppressive therapy regimen to treat adult...

22 jan 2021
The building information modeling software market is expected to grow by $ 8.38 bn, decelerate at a CAGR of over 24% during the forecast period. Click & Get Free Sample Report in Minutes The increasing requirements for large-scale project...

22 jan 2021
Lyft, Inc. today urged federal officials to ensure that drive through vaccination sites are accessible to people with mobility challenges. In a letter to the acting administrator of the Centers for Medicare & Medicaid Services, Megan Callahan, Vice...

22 jan 2021
Nagamasa Global, a commodity broker that aims to offer the highest level of customer service and transaction capability required by today's sophisticated financial market participants, today announced support of over 400 technology devices throughout...



News published on 25 november 2020 at 09:05 and distributed by: